M. Woodhead (Manchester, United Kingdom), S. Ewig (Bochum, Germany)
Sepsis severity is an excellent predictor of mortality in pneumococcal pneumonia
B. Schaaf, J. Kruse, J. Rupp, P. Zabel, K. Dalhoff (Lübeck, Germany)
|   |
Is severity index enough to assess hospital admission of community-acquired pneumonia (CAP) patients?
M. C. Aguar Benito, E. Fernández Fabrellas, A. L. Andreu Rodríguez, J. Blanquer Olivas, E. Chiner Vives, R. Blanquer Olivas, C. Ferrando, F. Tatay (Valencia, Spain)
| |
Prognostic factors of bacteremic pneumococcal pneumonia (BPP)
M. Garcia-Clemente, J. Allende, F. Alvarez-Navascues, A. Sanchez-Antuña, M. Martinez-Muñiz, J. M. Garcia-Garcia, M. Garcia-Marron, H. Villar (Aviles, Spain)
|  |
Genetic susceptibility to severe community-acquired pneumonia (CAP) in Buenos Aires
C. M. Luna, M. Gimenez, G. W. Waterer, S. E. Temple, M. Ortiz Ponce, R. G. Wunderink (Buenos Aires, Argentina; Perth, Australia; Chicago, United States Of America)
| |
Prospective evaluation of clinical and microbiological parameters in patients with community-acquired pneumonia with and without comorbidity
M. M. van der Eerden, F. Vlaspolder, C. S. de Graaff, H. M. Jansen, W. G. Boersma (Alkmaar, Amsterdam, Netherlands)
| |
Outcome of community aquired pneumonia in elderly patients
H. Kothe, T. Bauer, R. Marre, S. Norbert, T. Welte, K. Dalhoff (Lübeck, Berlin, Ulm, Hannover, Germany)
| |
Statin therapy and reduced risk of pneumonia in elderly patients with diabetes
E. M. W. van de Garde, E. Hak, P. C. Souverein, A. W. Hoes, J. M. M. van den Bosch, H. G. M. Leufkens (Utrecht, Nieuwegein, Netherlands)
| |
Are corticosteroids useful in community-acquired pneumonia?
P. Dambrava, G. Peñarroja, I. Aldabo, E. Mallorca, O. Sibila, M. A. Marcos, M. Camps, M. Sánchez, C. Agusti, J. Mensa, A. Torres (Barcelona, Spain)
| |